Clinical Trial Excellence: Winning Top Investigators in a Competitive Marketplace.CHAPEL HILL, N.C. -- "Doing your homework" captures what 45 world-class pharmaceutical and biotech bi·o·tech n. Informal Biotechnology. biotech Noun short for biotechnology Noun 1. companies, CROs and Clinical Investigation Sites describe as the key contributor to successful recruitment of top investigators. In its new 2004 study pharmaceutical research and consulting firm Noun 1. consulting firm - a firm of experts providing professional advice to an organization for a fee consulting company business firm, firm, house - the members of a business organization that owns or operates one or more establishments; "he worked for a Best Practices, LLC (Logical Link Control) See "LANs" under data link protocol. LLC - Logical Link Control identified best practices, tactics and tools used by industry leaders to recruit clinical investigators A clinical investigator involved in a clinical trial is responsible for ensuring that an investigation is conducted according to the signed investigator statement, the investigational plan, and applicable regulations; for protecting the rights, safety, and welfare of subjects under in a competitive marketplace. The comprehensive report, Clinical Trial Excellence: The Science & Art of Winning Investigators in a Competitive Marketplace, details best practices and managerial insights used by top companies to effectively recruit top talent for clinical trials. To purchase this study or to download a report excerpt ex·cerpt n. A passage or segment taken from a longer work, such as a literary or musical composition, a document, or a film. tr.v. ex·cerpt·ed, ex·cerpt·ing, ex·cerpts 1. , visit to http://www3.best-in-class.com/rr455.htm. Among its findings, the study shows practices that top performers consistently employ: --Relying on multiple sources, including external and internal sources, to identify top talent --Building and using databases efficiently and aligning them with your website to draw investigators --Using your website, toll-free phone lines, word-of-mouth and scientific meetings as ways for investigators to self-identify themselves for new trials --Engaging more investigators effectively in protocol design and testing --Productivity tactics to enhance patient yields per site --Optimal times to commence physician recruitment --New assessment techniques to evaluate site performance worthiness, viability --Segmentation techniques to profile physicians and site viability --Epidemiological mapping to align align ( v to move the teeth into their proper positions to conform to the line of occlusion. investigation sites with disease occurrence The findings in the report are drawn from in-depth interviews and surveys of executives at leading companies, including AstraZeneca, Covance, Baxter Healthcare, Bristol-Myers Squibb Bristol-Myers Squibb (NYSE: BMY), colloquially referred to as BMS, is a pharmaceutical corporation, formed by a 1989 merger between pharmaceutical companies Bristol-Myers Company, founded in 1887 by William McLaren Bristol and John Ripley Myers in Clinton, NY (both were , GlaxoSmithKline, Human Genome Sciences Human Genome Sciences NASDAQ: HGSI is a biopharmaceutical corporation founded in 1992. Its stated purpose is to "discover, develop, manufacture and market innovative drugs that serve patients with unmet medical needs, with a primary focus on protein and antibody drugs. , Pfizer, PPD (1) (Parallel Presence Detect) The method used by earlier SIMM memory modules to communicate their capacity to the computer. A binary number coming from a parallel set of pins was read by the system, with each pin representing one bit. Contrast with SPD. , Roche, and many more. The report includes specific examples, more than 180 metrics metrics Managed care A popular term for standards by which the quality of a product, service, or outcome of a particular form of Pt management is evaluated. See TQM. , and recommendations on how to identify and close performance gaps. Additionally, this study reveals how your organization can: --Increase the attractiveness and credibility of studies through effective positioning --Identify key opinion leaders and investigators for protocol design input and clinical trials --Evaluate the commitment and qualifications of these investigators --Create effective structures for both internal and external accountability --Partner with third parties to leverage clinical trial expertise To download a complementary report summary of Clinical Trial Excellence: The Science & Art of Winning Investigators in a Competitive Marketplace visit http://www3.best-in-class.com/rr455.htm. For more information, contact Dorris Huffstetler at (919) 767-9259 or at dhuffstetler@best-in-class.com. ABOUT BEST PRACTICES, LLC Best Practices, LLC is a research and consulting firm that conducts work based on the simple yet profound principle that organizations can chart a course to superior economic performance by studying the best business practices, operating tactics and winning strategies of world-class companies. For more information about Best Practices, LLC, call (919) 403-0251 or visit the corporate web site at http://www.best-in-class.com. |
|
||||||||||||

Printer friendly
Cite/link
Email
Feedback
Reader Opinion